Steris highlights new business structure and financial goals for 2016

Steris has announced its new financial outlook for 2016, while detailing a number of changes that will be made to the structure of the company.

Following the recent completion of its merger with Synergy Health in November 2015, the company is dividing its new-look organisation into four reporting business segments: healthcare products, healthcare specialty services, applied sterilisation technologies and life sciences.

A set process and a series of teams have been put in place to lead the integration of the two companies, with solid underlying performance expected for both businesses in the year to come.

As such, Steris anticipates combined year-on-year revenue growth of 21 to 22 percent when compared to its 2015 result of $1.85 billion (1.26 billion pounds). Adjusted earnings per diluted share, meanwhile, are anticipated to be in the range of $3.48 to $3.55.

Walt Rosebrough, president and chief executive officer of Steris, said: "While still in the early days, our integration efforts are progressing as anticipated, and we are excited about what we can achieve together."